by Elizabeth Kissling | Dec 13, 2009 | Advertising, Law/Legal, Media, Menopause
There’s a pretty good essay in this weekend’s New York Times (online here Saturday, in print Sunday in the Business section) about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. In addition to discussion of...
by Elizabeth Kissling | Dec 11, 2009 | Girls, Health Care, Law/Legal, New Research, Pharmaceutical
Today I want to point to two important articles about women’s health from our friends at Women’s eNews: Yesterday, they published a story about Myriad Genetics and their firm grasp on the patents for diagnostics tests for BRCA1 and BRCA2 genes, which are...
by Elizabeth Kissling | Nov 23, 2009 | Law/Legal, Menopause, Pharmaceutical
There are more than 10,000 lawsuits against Wyeth/Pfizer regarding the link between PremPro and breast cancer. There have been 12 verdicts so far, and juries have awarded money to the plaintiffs in ten of those cases. The latest was announced today, in Donna Kendall...
by Elizabeth Kissling | Nov 4, 2009 | Law/Legal, Menopause, Pharmaceutical
Even though the verdict regarding punitive damages awarded to Connie Barton in her suit against Prempro was sealed (as we wrote last week), the figure has leaked out. A Philadelphia jury awarded her $75 million in punitive damages, in addition to $3.7 million in...
by Elizabeth Kissling | Oct 27, 2009 | Law/Legal, Menopause, Pharmaceutical
Connie Barton, an Illinois woman who developed breast cancer after taking Prempro for menopausal symptoms, was awarded punitive damages by a jury in Philadelphia yesterday. The jury has already awarded her $3.7 million in compensatory damages, back in September, but...
